Recombinant multi-species HIVEP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HIVEP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of a family of closely related, large, zinc finger-containing transcription factors. The encoded protein regulates transcription by binding to regulatory regions of various cellular and viral genes that maybe involved in growth, development and metastasis. The protein contains the ZAS domain comprised of two widely separated regions of zinc finger motifs, a stretch of highly acidic amino acids and a serine/threonine-rich sequence. [provided by RefSeq, Nov 2012]
The Alternative Names of target: Gm20114,HIV-EP2,HIVEP2,Hivep2,Human immunodeficiency virus type I enhancer-binding protein 2 (HIV-EP2),MBP-2,MHC-binding protein 2 (MBP-2),MIBP-1,MIBP1,MRD43,SHN2,Schnurri-2,Shn-2,Transcription factor HIVEP2,ZAS2,ZNF40B
Go
to HIVEP2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP7938-Ag-1/ GM-Tg-hg-IP7938-Ag-2 | Human HIVEP2 protein | Human |
GM-Tg-rg-IP7938-Ag-1/ GM-Tg-rg-IP7938-Ag-2 | Rat HIVEP2 protein | Rat |
GM-Tg-mg-IP7938-Ag-1/ GM-Tg-mg-IP7938-Ag-2 | Mouse HIVEP2 protein | Mouse |
GM-Tg-cynog-IP7938-Ag-1/ GM-Tg-cynog-IP7938-Ag-2 | Cynomolgus/Rhesus macaque HIVEP2 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP7938-Ag-1/ GM-Tg-felg-IP7938-Ag-2 | Feline HIVEP2 protein | Feline |
GM-Tg-cang-IP7938-Ag-1/ GM-Tg-cang-IP7938-Ag-2 | Canine HIVEP2 protein | Canine |
GM-Tg-bovg-IP7938-Ag-1/ GM-Tg-bovg-IP7938-Ag-2 | Bovine HIVEP2 protein | Bovine |
GM-Tg-equg-IP7938-Ag-1/ GM-Tg-equg-IP7938-Ag-2 | Equine HIVEP2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP7938-Ag-1/ GM-Tg-hg-IP7938-Ag-2;
GM-Tg-rg-IP7938-Ag-1/ GM-Tg-rg-IP7938-Ag-2;
GM-Tg-mg-IP7938-Ag-1/ GM-Tg-mg-IP7938-Ag-2; GM-Tg-cynog-IP7938-Ag-1/ GM-Tg-cynog-IP7938-Ag-2; GM-Tg-felg-IP7938-Ag-1/ GM-Tg-felg-IP7938-Ag-2; GM-Tg-cang-IP7938-Ag-1/ GM-Tg-cang-IP7938-Ag-2; GM-Tg-bovg-IP7938-Ag-1/ GM-Tg-bovg-IP7938-Ag-2; GM-Tg-equg-IP7938-Ag-1/ GM-Tg-equg-IP7938-Ag-2 |
Products Name | HIVEP2 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | HIVEP2 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HIVEP2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.